deltatrials

Ischemic stroke Trials in Shenyang, China

Conditions / Ischemic stroke / Shenyang, China

Ischemic stroke has been the subject of sustained clinical investigation across multiple research sites.

28 total trials for this combination

Showing top 10 of 28 trials

Trials

NCT ID Title Status Phase
NCT06601127 Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE). RECRUITING PHASE2
NCT02869009 Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke COMPLETED PHASE3
NCT06615726 Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis ACTIVE_NOT_RECRUITING PHASE3
NCT04664946 Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT) RECRUITING NA
NCT04811651 Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke COMPLETED PHASE2
NCT05507645 ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE) COMPLETED PHASE3
NCT05439356 Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3) COMPLETED PHASE3
NCT01958957 A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke. COMPLETED PHASE4
NCT03494920 DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval COMPLETED PHASE3
NCT01762163 Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke COMPLETED PHASE4

Related Pages